CareRx Corporation (CHHHF)
USD 1.88
(-1.05%)
USD 1.88
(-1.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.67 Million CAD | -8.66% |
| 2022 | 7.91 Million CAD | 67.82% |
| 2021 | 4.71 Million CAD | 260.45% |
| 2020 | -2.93 Million CAD | -5.49% |
| 2019 | -2.78 Million CAD | 74.57% |
| 2018 | -10.95 Million CAD | -1199.6% |
| 2017 | 996 Thousand CAD | 129.52% |
| 2016 | -3.37 Million CAD | 70.42% |
| 2015 | -11.4 Million CAD | -118.99% |
| 2014 | -5.2 Million CAD | 60.82% |
| 2013 | -13.29 Million CAD | -43.39% |
| 2012 | -9.26 Million CAD | -117.12% |
| 2011 | 54.15 Million CAD | 649.27% |
| 2010 | 7.22 Million CAD | 143.33% |
| 2009 | 2.97 Million CAD | 76.67% |
| 2008 | 1.68 Million CAD | 56.39% |
| 2007 | 1.07 Million CAD | 283.73% |
| 2006 | 280.12 Thousand CAD | 149.93% |
| 2005 | -561.05 Thousand CAD | -217.06% |
| 2004 | 479.3 Thousand CAD | -56.12% |
| 2003 | 1.09 Million CAD | 1925.94% |
| 2002 | -59.81 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 2.32 Million CAD | -54.44% |
| 2024 Q1 | 2.15 Million CAD | 1.94% |
| 2023 Q3 | 2.08 Million CAD | 103.91% |
| 2023 Q1 | 1.5 Million CAD | 160.31% |
| 2023 Q4 | 2.11 Million CAD | 1.15% |
| 2023 FY | 7.22 Million CAD | -8.66% |
| 2023 Q2 | 1.02 Million CAD | -31.89% |
| 2022 Q2 | 2.76 Million CAD | 5.93% |
| 2022 Q3 | 1.89 Million CAD | -31.5% |
| 2022 Q4 | 577 Thousand CAD | -69.57% |
| 2022 FY | 7.91 Million CAD | 67.82% |
| 2022 Q1 | 2.61 Million CAD | -66.58% |
| 2021 Q4 | 7.81 Million CAD | 800.54% |
| 2021 Q3 | -1.11 Million CAD | 41.51% |
| 2021 Q2 | -1.9 Million CAD | -355.37% |
| 2021 Q1 | -419 Thousand CAD | 65.05% |
| 2021 FY | 4.71 Million CAD | 260.45% |
| 2020 Q2 | -8.07 Million CAD | -253.88% |
| 2020 Q1 | -2.28 Million CAD | -21.39% |
| 2020 FY | -2.93 Million CAD | -5.49% |
| 2020 Q3 | -772 Thousand CAD | 90.44% |
| 2020 Q4 | -1.19 Million CAD | -55.31% |
| 2019 Q2 | -1.12 Million CAD | 23.73% |
| 2019 Q1 | -1.47 Million CAD | 82.82% |
| 2019 FY | -2.78 Million CAD | 74.57% |
| 2019 Q4 | -1.87 Million CAD | -146.26% |
| 2019 Q3 | -763 Thousand CAD | 32.36% |
| 2018 Q2 | -52 Thousand CAD | -110.83% |
| 2018 Q4 | -8.61 Million CAD | -246.1% |
| 2018 FY | -10.95 Million CAD | -1199.6% |
| 2018 Q1 | 480 Thousand CAD | 174.65% |
| 2018 Q3 | -2.48 Million CAD | -4684.62% |
| 2017 Q1 | 668 Thousand CAD | -18.64% |
| 2017 FY | 996 Thousand CAD | 129.52% |
| 2017 Q4 | -643 Thousand CAD | -238.58% |
| 2017 Q3 | 464 Thousand CAD | -70.8% |
| 2017 Q2 | 1.58 Million CAD | 137.87% |
| 2016 Q1 | -1.19 Million CAD | 86.99% |
| 2016 Q2 | -2.77 Million CAD | -131.69% |
| 2016 FY | -3.37 Million CAD | 70.42% |
| 2016 Q3 | -218 Thousand CAD | 92.15% |
| 2016 Q4 | 821 Thousand CAD | 476.61% |
| 2015 FY | -11.4 Million CAD | -118.99% |
| 2015 Q1 | -2.31 Million CAD | 0.47% |
| 2015 Q4 | -9.21 Million CAD | -5259.3% |
| 2015 Q3 | -172 Thousand CAD | -156.58% |
| 2015 Q2 | 304 Thousand CAD | 113.12% |
| 2014 Q3 | -1.47 Million CAD | -1651.19% |
| 2014 FY | -5.2 Million CAD | 60.82% |
| 2014 Q1 | -3.53 Million CAD | 67.13% |
| 2014 Q4 | -2.32 Million CAD | -58.26% |
| 2014 Q2 | -84 Thousand CAD | 97.62% |
| 2013 FY | -13.29 Million CAD | -43.39% |
| 2013 Q3 | -288 Thousand CAD | 74.65% |
| 2013 Q2 | -1.13 Million CAD | -1.88% |
| 2013 Q1 | -1.11 Million CAD | 95.19% |
| 2013 Q4 | -10.75 Million CAD | -3633.68% |
| 2012 Q4 | -23.16 Million CAD | -1119.09% |
| 2012 Q2 | 5.62 Million CAD | 30.27% |
| 2012 Q1 | 4.31 Million CAD | 106.51% |
| 2012 Q3 | 2.27 Million CAD | -59.56% |
| 2012 FY | -9.26 Million CAD | -117.12% |
| 2011 Q4 | -66.26 Million CAD | -970.67% |
| 2011 Q2 | 2.07 Million CAD | 196.99% |
| 2011 Q3 | 7.61 Million CAD | 267.68% |
| 2011 Q1 | 697 Thousand CAD | -48.1% |
| 2011 FY | 54.15 Million CAD | 649.27% |
| 2010 Q1 | 1.71 Million CAD | 1381.03% |
| 2010 FY | 7.22 Million CAD | 143.33% |
| 2010 Q2 | 2.18 Million CAD | 27.24% |
| 2010 Q4 | 1.34 Million CAD | -32.21% |
| 2010 Q3 | 1.98 Million CAD | -9.38% |
| 2009 Q3 | 1.51 Million CAD | 89.49% |
| 2009 Q1 | 540.14 Thousand CAD | -13.26% |
| 2009 Q2 | 799 Thousand CAD | 47.92% |
| 2009 FY | 2.97 Million CAD | 76.67% |
| 2009 Q4 | 116 Thousand CAD | -92.34% |
| 2008 Q3 | 308.28 Thousand CAD | -28.31% |
| 2008 Q4 | 622.73 Thousand CAD | 102.0% |
| 2008 FY | 1.68 Million CAD | 56.39% |
| 2008 Q1 | 320.03 Thousand CAD | 99.61% |
| 2008 Q2 | 430.04 Thousand CAD | 34.37% |
| 2007 Q3 | 174.69 Thousand CAD | -58.57% |
| 2007 Q2 | 421.7 Thousand CAD | 6.32% |
| 2007 Q1 | 396.64 Thousand CAD | 235.82% |
| 2007 FY | 1.07 Million CAD | 283.73% |
| 2007 Q4 | 160.33 Thousand CAD | -8.22% |
| 2006 Q1 | 235.3 Thousand CAD | 462.68% |
| 2006 FY | 280.12 Thousand CAD | 149.93% |
| 2006 Q2 | 256.91 Thousand CAD | 9.19% |
| 2006 Q4 | -292.03 Thousand CAD | -465.31% |
| 2006 Q3 | 79.94 Thousand CAD | -68.88% |
| 2005 Q3 | 43.16 Thousand CAD | 111.09% |
| 2005 Q1 | -150.1 Thousand CAD | -130.3% |
| 2005 FY | -561.05 Thousand CAD | -217.06% |
| 2005 Q2 | -389.23 Thousand CAD | -159.31% |
| 2005 Q4 | -64.87 Thousand CAD | -250.3% |
| 2004 Q2 | 285.66 Thousand CAD | 1.03% |
| 2004 FY | 479.3 Thousand CAD | -56.12% |
| 2004 Q4 | -65.17 Thousand CAD | -176.39% |
| 2004 Q3 | -23.58 Thousand CAD | -108.25% |
| 2004 Q1 | 282.75 Thousand CAD | -44.37% |
| 2003 Q2 | 225.96 Thousand CAD | 602.3% |
| 2003 Q1 | -44.98 Thousand CAD | -218.08% |
| 2003 FY | 1.09 Million CAD | 1925.94% |
| 2003 Q4 | 508.31 Thousand CAD | 285.14% |
| 2003 Q3 | 131.98 Thousand CAD | -41.59% |
| 2002 Q4 | -14.14 Thousand CAD | 59.01% |
| 2002 Q3 | -34.5 Thousand CAD | -208.89% |
| 2002 FY | -59.81 Thousand CAD | 0.0% |
| 2002 Q2 | -11.17 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -25.84 Million USD | 118.072% |
| Arem Pacific Corporation | -23.6 Thousand USD | 19887.297% |
| Assisted 4 Living, Inc. | -121.58 Thousand USD | 3941.061% |
| BioCorRx Inc. | -3.78 Million USD | 223.291% |
| Bionik Laboratories Corp. | -4.82 Million USD | 196.787% |
| Banyan Corp. | -1.59 Million USD | 392.995% |
| Clearday, Inc. | -11.85 Million USD | 139.402% |
| Dental Patient Care America, Inc. | -31.55 Thousand USD | 14898.618% |
| Quantum Medical Transport, Inc. | 222.84 USD | -2095574.026% |
| Empower Clinics Inc. | -4.95 Million USD | 194.261% |
| First Choice Healthcare Solutions, Inc. | -2.41 Million USD | 293.741% |
| Selectis Health, Inc. | -8.96 Million USD | 152.118% |
| Ethema Health Corporation | -541.92 Thousand USD | 961.751% |
| HealthLynked Corp. | -3.83 Million USD | 221.876% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 275.935% |
| JRSIS Health Care Corporation | -188.59 Thousand USD | 2576.166% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 67.1 Million USD | 93.041% |
| MedSmart Group Inc. | -84.51 Thousand USD | 5625.973% |
| North America Frac Sand, Inc. | -702.5 Thousand USD | 764.769% |
| Nova Leap Health Corp. | 460.15 Thousand USD | -914.882% |
| Nexteligent Holdings, Inc. | -201.72 Thousand USD | 2415.021% |
| PAO Group, Inc. | -45.42 Thousand USD | 10381.814% |
| Primemd Inc. | 4.15 Million USD | -12.293% |
| Raffles Medical Group Ltd | 87.71 Million USD | 94.676% |
| Ryman Healthcare Limited | -26.98 Million USD | 117.304% |
| Stem Cell Authority, Ltd. | -4230.00 USD | 110501.891% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.25 Million USD | 307.483% |
| Mycotopia Therapies, Inc. | -616.72 Thousand USD | 857.227% |
| U.S. NeuroSurgical Holdings, Inc. | -765 Thousand USD | 710.458% |
| Veltex Corporation | -1.08 Million USD | 531.399% |
| World Financial Holding Group | -28.43 Thousand USD | 16526.31% |
| Xcelerate Inc. | -2.61 Million USD | 278.745% |